H.R. 2319Passed one chamberHealth care
Bill directs federal review of lung cancer research for women, veterans
Data as of July 23, 2026
HR 2319 requires HHS to review lung cancer research on women and underserved groups and report to Congress within two years.AI-decoded40-second read · 4 questions answered below
Decoded
AI-decodedWhat does this do?
HR 2319 directs HHS, working with the Defense Department and Veterans Affairs, to review existing lung cancer research related to women and underserved populations, identify knowledge gaps, and explore opportunities for new studies. It also asks HHS to consider a national screening strategy and a public awareness campaign. The bill requires only a study and report, not new programs or direct treatment funding.
Who does it affect?
Government health agencies and researchers at HHS, the Defense Department, and Veterans Affairs would conduct the review. Women, veterans, and underserved populations such as low-income or rural communities could be indirectly affected by future findings.
Why does it matter?
The review could inform future screening guidelines, research funding, or awareness campaigns, but the bill itself creates no immediate changes to care or policy.
Where does it stand?
- Introduced
- House committee
- House vote
- Senate — You are here
- President's desk
Right now: it passed the House and now goes to the Senate. If the Senate changes it, it goes back to the House before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Make the call
Three steps: where you stand, your script, the call.
See how a call works
Official title
Women and Lung Cancer Research and Preventive Services Act of 2025
- Introduced:
- March 25, 2025
- Latest action:
- April 22, 2026
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
Read the official bill on Congress.gov